Crossmark

An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0

Crossref DOI link: https://doi.org/10.1186/s40425-018-0362-6

Published Online: 2018-05-30

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sullivan, Ryan J.

Atkins, Michael B.

Kirkwood, John M.

Agarwala, Sanjiv S.

Clark, Joseph I.

Ernstoff, Marc S.

Fecher, Leslie

Gajewski, Thomas F.

Gastman, Brian

Lawson, David H.

Lutzky, Jose

McDermott, David F.

Margolin, Kim A.

Mehnert, Janice M.

Pavlick, Anna C.

Richards, Jon M.

Rubin, Krista M.

Sharfman, William

Silverstein, Steven

Slingluff, Craig L.

Sondak, Vernon K.

Tarhini, Ahmad A.

Thompson, John A.

Urba, Walter J.

White, Richard L.

Whitman, Eric D.

Hodi, F. Stephen

Kaufman, Howard L.
License Information

Text and Data Mining valid from 2018-05-30
More Information

Article History

Received: 12 January 2018

Accepted: 17 May 2018

First Online: 30 May 2018

Ethics approval and consent to participate

: Not applicable.

: RJS, MBA, JMK, SA, JIC, MSE, LF, TFG, BG, DHL, JL, DFM, KAM, JMM, JMR, KMR, WS, SS, VKS, AAT, WJU, RLW, EDW, FSH, HLK. The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.